Company Profile
Soiken develops biomarkers in Japan. It is involved in the development and sale of cosmetics and dietary supplements comprising imidapeptides. Its portfolio also includes licensing and development of biomarker technology, provision of marketing research and post-marketing surveys for dietary supplements, and research, development, and sale of functional materials, such as lactoferrin
Pharmaceutical products from ascochlorin derivatives, as well as clinical evaluation tests for foodstuffs using biomarker technology. Its portfolio also includes support for pharmaceutical clinical research and epidemiology studies, and services to health insurance societies
Including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. Incorporated in 1994, Soiken is headquartered in Toyonaka, Japan.